Neurophysiological Effects of Transcutaneous Electrical Nerve Stimulation in Persons With MS
Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · May 22, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called Transcutaneous Electrical Nerve Stimulation (TENS) on people with Multiple Sclerosis (MS). TENS is a method that sends small electrical signals through the skin to help reduce fatigue and improve walking abilities, which are common challenges for those living with MS. The goal of this study is to better understand how TENS affects brain activity using a special imaging technique called fMRI.
To participate, you need to be between 18 and 65 years old and have a specific level of disability related to MS, measured by a scale called EDSS (with a score less than 7). Unfortunately, not everyone can join; for example, you cannot have certain medical implants, weigh over a certain amount, or have other serious health conditions. If you are eligible and choose to participate, you can expect to undergo some tests to see how TENS affects your brain and symptoms. This research could help improve treatments for MS in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age: 18-65 years
- • EDSS score \< 7
- Exclusion Criteria:
- • metal or electrical implants
- • BMI \> 40
- • claustrophobia
- • being pregnant
- • having a psychiatric disorder
- • having cognitive or communication problems which reduces the capacity to understand instructions
- • having a neurological disorder other than MS
- • having cardiac arrhythmia
About University Medical Center Groningen
University Medical Center Groningen (UMCG) is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research, high-quality patient care, and extensive education in the medical field. As a prominent sponsor of clinical trials, UMCG leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into effective treatments that enhance patient health and well-being. With a focus on ethical standards and regulatory compliance, UMCG is dedicated to conducting clinical trials that contribute to the advancement of medicine and the betterment of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported